A Primer on Detecting Cirrhosis and Caring for These Patients Without Causing Harm

Overview

Journal Int J Hepatol

Publisher Wiley

Specialty Gastroenterology

Date 2011 Nov 29

PMID 22121492

Citations 9

Authors

Bruce Allen Runyon

Affiliations

Soon will be listed here.

Abstract

Many people who have cirrhosis are undiagnosed. The diagnosis may not become evident until they develop multiorgan failure after an invasive procedure. Patients with cirrhosis are unusually fragile and can be easily harmed and even set into a fatal down-spiral by seemingly innocuous treatments including medications and invasive procedures. There is much confusion regarding the care of these patients. For example, what medications can be used safely to treat pain, what sedatives are safe and effective, which medications are to be avoided, what diet should be prescribed, and which invasive procedures are safe. This paper provides the author's advice regarding clues to the presence of cirrhosis and the dos and do nots in the general care of these patients, based on his 30 years of experience in a liver-failure-focused academic practice.

Citing Articles

Association Between End-Stage Liver Disease and Incident Heart Failure in an Integrated Health System.

Chuzi S, Tanaka Y, Bavishi A, Bruce M, Van Wagner L, Wilcox J J Gen Intern Med. 2023; 38(11):2445-2452.

PMID: 37095330 PMC: 10465455. DOI: 10.1007/s11606-023-08199-z.

The Risk of Tuberculosis Infection in Non-dialysis Chronic Kidney Disease Patients.

Li C, Chen H, Chen W, Tu C, Hsia T, Hsu W Front Med (Lausanne). 2021; 8:715010.

PMID: 34485344 PMC: 8409506. DOI: 10.3389/fmed.2021.715010.

Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis.

Martinez-Urbistondo D, Suarez Del Villar R, Argemi J, Daimiel L, Ramos-Lopez O, San-Cristobal R Antioxidants (Basel). 2020; 9(11).

PMID: 33202851 PMC: 7696605. DOI: 10.3390/antiox9111125.

Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review.

Ballestri S, Capitelli M, Fontana M, Arioli D, Romagnoli E, Graziosi C Adv Ther. 2020; 37(5):1910-1932.

PMID: 32285340 PMC: 7467481. DOI: 10.1007/s12325-020-01307-z.

Evaluation of the United Kingdom-primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population.

Alomari M, Covut F, Al Momani L, Chadalavada P, Hitawala A, Young M JGH Open. 2020; 4(2):132-139.

PMID: 32280755 PMC: 7144790. DOI: 10.1002/jgh3.12223.

References

Kuehn B . Alarming nonfatal overdose rates found for opioids, sedatives, and tranquilizers. JAMA. 2010; 303(20):2020-1. DOI: 10.1001/jama.2010.641. View

Hu K, Kyulo N, Esrailian E, Thompson K, Chase R, Hillebrand D . Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States. J Hepatol. 2003; 40(1):147-54. DOI: 10.1016/s0168-8278(03)00479-3. View

de Ledinghen V, Mannant P, Foucher J, Perault M, Barrioz T, Ingrand P . Non-steroidal anti-inflammatory drugs and variceal bleeding: a case-control study. J Hepatol. 1996; 24(5):570-3. DOI: 10.1016/s0168-8278(96)80142-5. View

Russo M, Wei J, Thiny M, Gangarosa L, Brown A, Ringel Y . Digestive and liver diseases statistics, 2004. Gastroenterology. 2004; 126(5):1448-53. DOI: 10.1053/j.gastro.2004.01.025. View

Nair S . Vitamin d deficiency and liver disease. Gastroenterol Hepatol (N Y). 2010; 6(8):491-3. PMC: 2950664. View

Runyon B, Hoefs J, Morgan T . Ascitic fluid analysis in malignancy-related ascites. Hepatology. 1988; 8(5):1104-9. DOI: 10.1002/hep.1840080521. View

Powell E, Cooksley W, Hanson R, Searle J, Halliday J, Powell L . The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990; 11(1):74-80. DOI: 10.1002/hep.1840110114. View

Veldt B, Laine F, Guillygomarch A, Lauvin L, Boudjema K, Messner M . Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol. 2002; 36(1):93-8. DOI: 10.1016/s0168-8278(01)00228-8. View

Yamini D, Lee S, Avanesyan A, Walter M, Runyon B . Utilization of baclofen in maintenance of alcohol abstinence in patients with alcohol dependence and alcoholic hepatitis with or without cirrhosis. Alcohol Alcohol. 2014; 49(4):453-6. DOI: 10.1093/alcalc/agu028. View

10.

Burki T . Changing drinking patterns: a sobering thought. Lancet. 2010; 376(9736):153-4. DOI: 10.1016/s0140-6736(10)61095-1. View

11.

Bruix J, Sherman M . Management of hepatocellular carcinoma. Hepatology. 2005; 42(5):1208-36. DOI: 10.1002/hep.20933. View

12.

Mayo M, Handem I, Saldana S, Jacobe H, Getachew Y, Rush A . Sertraline as a first-line treatment for cholestatic pruritus. Hepatology. 2007; 45(3):666-74. DOI: 10.1002/hep.21553. View

13.

Kamath P, Kim W . The model for end-stage liver disease (MELD). Hepatology. 2007; 45(3):797-805. DOI: 10.1002/hep.21563. View

14.

Haq S, Dayal H . Chronic liver disease and consumption of raw oysters: a potentially lethal combination--a review of Vibrio vulnificus septicemia. Am J Gastroenterol. 2005; 100(5):1195-9. DOI: 10.1111/j.1572-0241.2005.40814.x. View

15.

Williams C, Stengel J, Asike M, Torres D, Shaw J, Contreras M . Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2010; 140(1):124-31. DOI: 10.1053/j.gastro.2010.09.038. View

16.

Radvan G, Vidikan P . Meralgia paresthetica and liver disease. Ann Intern Med. 1982; 96(2):252-3. DOI: 10.7326/0003-4819-96-2-252. View

17.

Marin D, Furlan A, Federle M, Midiri M, Brancatelli G . Imaging approach for evaluation of focal liver lesions. Clin Gastroenterol Hepatol. 2009; 7(6):624-34. DOI: 10.1016/j.cgh.2009.03.024. View

18.

Garcia-Tsao G, Sanyal A, Grace N, Carey W . Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007; 46(3):922-38. DOI: 10.1002/hep.21907. View

19.

Petta S, Camma C, Scazzone C, Tripodo C, Di Marco V, Bono A . Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010; 51(4):1158-67. DOI: 10.1002/hep.23489. View

20.

Aube C, Oberti F, Korali N, Namour M, Loisel D, Tanguy J . Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol. 1999; 30(3):472-8. DOI: 10.1016/s0168-8278(99)80107-x. View